Dan Blumenthal

Dan Blumenthal has a diverse work experience in the healthcare industry. Dan started their career at Cardiovascular Associates of America as the President of the Novocardia Division in 2023. Before that, they worked at Massachusetts General Hospital from 2011 to 2017, holding various roles such as Attending Physician, Clinical Fellow, Chief Fellow, and Resident in the Division of Cardiology. In 2017, they joined Harvard Medical School - Massachusetts General Hospital as an Instructor, maintaining an outpatient general cardiology clinic. Dan also founded and served as the CEO of Novocardia from 2020 to 2023. Additionally, they have worked at Devoted Health as an Advisor, National Medical Director, Associate Chief Medical Officer, and in Clinical Operations. Dan has experience as a Consultant at Precision Health Economics and served as an Advisory Board Member at HLM Venture Partners. Dan has also worked as an Advisor at Exercise.com and was a Founding Member of Crimson Care Collaborative, a student-faculty collaborative primary care clinic. Dan started their career as a Research Associate and Case Writer at the Global Health Delivery Project, where they wrote a case study about India's National Polio Elimination Program.

Dan Blumenthal earned a Magna Cum Laude B.A. degree in Government from Harvard University in 2002. Dan then attended Harvard Medical School and obtained their MD degree in Medicine from 2006 to 2011. During this time, they also pursued an MBA degree in Management, Operations, and Healthcare Delivery from Harvard Business School, completing it in 2011. There is no specific information available about their education prior to attending Harvard University or any additional degrees earned after their MD degree.